Friday, July 31, 2026

South Korea Pushes for Fukushima-Level Scrutiny on North’s Suspected Water Leak

Kim Sung Hwan, nominee for South Korea's Environment Minister, addresses radioactive water concerns from North Korea, emphasizing public health.

Hyun Geun-taek’s Acquittal Explained: Key Takeaways from the Court’s Decision on North Korea Fund Transfer Case

Former Suwon Vice Mayor Hyun Geun-taek's charges related to document leaks were dismissed due to procedural violations, clarifying prosecutorial limits.

North Korea’s Latest Provocation: 66 Trash Balloons Land in South Korea

According to the Northern Gyeonggi Police Agency, 66 trash balloons were reported at 5 a.m. today, with 42 handed over to the military.

Tag: production

How KAIST’s Quinone-Titanium Catalyst Could Transform Energy Production in 2026

A KAIST research team developed a stable molecular catalyst combining quinone and titanium, enhancing artificial energy production methods.

Celltrion’s 1 Trillion KRW Investment: A Game Changer for Biopharmaceutical Production by 2030

Celltrion plans a major expansion with over 1 trillion KRW investment, boosting production capacity for biosimilars and new drugs by 2030.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

China Set to Overtake South Korea in OLED Production by 2029

China's OLED production is set to surpass South Korea's by 2029, driven by aggressive investments and growth in display technology.

Samsung Biologics CEO John Rim Poised for Third Term: What This Means for the Global CDMO Market in 2026

John Rim of Samsung Biologics aims for a third term, leading record growth and expansion into next-gen therapies amid global challenges.

CGBio’s NovoFactory: A Game-Changer for Bone Graft Products in the U.S. and Japan

CGBio's new Novo Factory in Hwaseong receives approval to produce Novosis Putty, targeting advanced markets like the U.S. and Japan.

Samsung Biologics: How a 56 Billion USD CDMO Leader is Shaping the Future of Biopharmaceuticals

Samsung Biologics is evolving as a leading CDMO, targeting a production capacity of 1.32M liters by 2030 after its spin-off from Bioepis.

Hyderabad’s New CKD Production Line: How Huons Meditech and Vasu Group are Revolutionizing Endoscope Sterilizers in India

Huons Meditech inaugurated a CKD production line for endoscope disinfectors in India, enhancing local production and market expansion.

Samsung Biologics Partners with CEPI: A Game-Changer for Global Vaccine Production

Samsung Biologics partners with CEPI to enhance vaccine production for pandemics, aiming for rapid global supply and health security.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

Chinese & Indian Medical Invasion: Pharmaceutic Dependency on Risk of Essential Medicine Supply

Concerns rise over South Korea's API industry reliance on China and India, with self-sufficiency at a record low of 25.6% in 2023.

Kia Introduces Lego-Like Flexible Body System for Purpose-Built Vehicle Lineup

Kia announced the application of its next-generation 'Flexible Body System' for its first purpose-built vehicle, the 'PV5', set for release this year.

China Launches Mass Production of Humanoid Robots, Signaling New Tech Era

China's humanoid robot industry is set for mass production, with rising shipments and global interest, signaling rapid growth ahead.

China’s BYD Cuts Back Production, Fueling EV Market Jitters

BYD is slowing production and cutting shifts amid falling sales, impacting stock performance and prompting aggressive pricing strategies.

Top News

- Our Sponsors Ad -

Follow us